News | September 22, 2014

New Study Suggests Benefit of Screening on Breast Cancer Deaths

An accompanying editorial says this study largely confirms what is already known — that the benefits of breast screening "are modest at best" — and calls for women to be given balanced information including the screening harms of over diagnosis, psychological stress and high healthcare costs.

Study Mammography Screening Benefits Breast Cancer Deaths Women's Healthcare

September 22, 2014 — Randomized trials from the 1970s and 80s suggested that mammography screening prevents deaths from breast cancer. But the methods used by some of these studies have been criticized, and this has raised doubts about the validity of the findings. Advances in technology and treatment have also led to questions about the reliability of older trials to estimate the benefits and harms of modern day screening.

So, researchers in Norway set out to evaluate the effectiveness of modern mammography screening by comparing the effects on breast cancer mortality among screened and unscreened women.

They analyzed data from all women in Norway aged 50 to 79 between 1986 and 2009 — the period during which the Norwegian mammography screening program was gradually implemented. They compared deaths from breast cancer among women who were invited to screening with those who were not invited, making a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening.

They also used a simulation model to estimate how many women aged 50-69 years would need to be invited to screening every two years to prevent one breast cancer death during their lifetime.

Based on more than 15 million person years of observation, breast cancer deaths occurred in 1,175 of the women invited to screening and in 8,996 of the women who were not invited.

After adjusting for factors such as age, area of residence and underlying trends in breast cancer mortality, the researchers estimate that invitation to mammography screening was associated with a 28 percent reduced risk of death from breast cancer compared with not being invited to screening. The screening effect persisted, but gradually declined with time after invitations to screening ended at 70 years of age.

Using the simulation model, they also estimate that 368 women aged 50-69 would need to be invited to screening every two years to prevent one death from breast cancer during their lifetime. Further analysis to test the strength of the findings did not substantially change the results.

"In our study, the estimated benefit for breast cancer mortality (28 percent) associated with invitation to mammography screening indicates a substantial effect," say the authors. But evolving improvements in treatment "will probably lead to a gradual reduction in the absolute benefit of screening," they conclude.

This study "adds important information to a growing body of observational evidence estimating the benefits and harms of screening," say U.S. researchers in an accompanying editorial, and should "make us reflect on how to monitor the changing benefits and harms of breast cancer screening." They call for women to be given balanced information to help them make informed decisions about screening.

For more information: www.bmj.com/content/348/bmj.g3701

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...